Stock comparison
REVVITY, INC. is 1.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($12.74 B vs $8.09 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
RVTY is larger
REVVITY, INC. is 1.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($12.74 B vs $8.09 B).
Market value leader
RVTY
REVVITY, INC. is 1.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($12.74 B vs $8.09 B).
Revenue leader
RVTY
BIO: $2.58B vs RVTY: $2.86B.
Profit leader
BIO
BIO: $759.90M vs RVTY: $241.20M.
Margin leader
BIO
BIO: 29.4% vs RVTY: 8.4% net margin.
| Metric | BIO | RVTY |
|---|---|---|
| Market cap | $8.09 B | $12.74 B |
| US-listed rank | #1083 | #815 |
| Revenue (latest FY) | $2.58B | $2.86B |
| Net income (latest FY) | $759.90M | $241.20M |
| Net margin | 29.4% | 8.4% |
| P/E (trailing FY) | 10.6x | 52.8x |
| SEC filings | 1,494 | 1,745 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
REVVITY, INC. is 1.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($12.74 B vs $8.09 B).
In their latest fiscal years, Bio-Rad Laboratories, Inc. reported $2.58B in revenue while REVVITY, INC. reported $2.86B.
Full pages: Bio-Rad Laboratories, Inc. and REVVITY, INC., or browse the full rankings.